Avian Influenza (AI / Bird flu)

Avian influenza, commonly known as bird flu, is a highly contagious viral disease caused by type A influenza viruses that naturally circulate among wild aquatic birds and can infect domestic poultry with devastating consequences. The disease represents one of the most significant health and economic threats facing the global poultry industry, with outbreaks resulting in the culling of hundreds of millions of birds, massive economic losses, and disruptions to international trade in poultry products. Avian influenza viruses are classified into two pathotypes based on their virulence in chickens: low pathogenic avian influenza strains that typically cause mild respiratory disease, and highly pathogenic avian influenza strains that cause severe systemic disease with mortality rates approaching one hundred percent in susceptible poultry species.

The disease affects all species of domestic poultry, although susceptibility and clinical presentation vary considerably among different bird types. Chickens and turkeys are highly susceptible to both low and highly pathogenic strains, while domestic ducks and geese may carry and shed the virus with minimal or no clinical signs, serving as potential sources of infection for more susceptible species. Wild waterfowl, particularly ducks, geese, and shorebirds, serve as the natural reservoir for avian influenza viruses and can introduce infection to domestic flocks through direct contact, contaminated water sources, or environmental contamination. This wildlife reservoir makes complete eradication of avian influenza impossible and necessitates ongoing vigilance and preparedness.

The economic impact of avian influenza extends far beyond the direct costs of bird mortality and depopulation to include trade restrictions, market disruptions, and the substantial resources required for surveillance, response, and prevention programs. Major outbreaks have resulted in billions of dollars in losses to the poultry industry, with effects rippling through the entire food supply chain from producers to consumers. Trade restrictions imposed by importing countries in response to disease detection can persist long after outbreaks are controlled, causing extended economic hardship for affected regions. The costs of maintaining adequate biosecurity and surveillance programs represent ongoing investments that producers must incorporate into their operations.

Beyond its impact on poultry, avian influenza has significant public health implications due to the potential for certain strains to infect humans and cause severe, sometimes fatal, respiratory illness. While human infections have been relatively rare and generally associated with close contact with infected poultry, the concern that avian influenza viruses could mutate or reassort to acquire the ability for sustained human-to-human transmission drives intensive global surveillance and preparedness efforts. This zoonotic potential elevates avian influenza from a purely agricultural concern to a matter of international public health security, requiring coordinated responses across veterinary, medical, and governmental sectors.

Avian influenza is caused by type A influenza viruses belonging to the family Orthomyxoviridae, characterized by a segmented, negative-sense RNA genome that facilitates the genetic reassortment responsible for the emergence of new viral strains. These viruses are classified based on two surface proteins: hemagglutinin, of which eighteen subtypes have been identified, and neuraminidase, with eleven known subtypes. The combination of these proteins determines the viral subtype designation, such as H5N1, H7N9, or H9N2, with different subtypes varying in their host range, virulence, and zoonotic potential. Highly pathogenic avian influenza strains have historically been limited to the H5 and H7 subtypes, although not all H5 and H7 viruses are highly pathogenic, and the distinction between low and high pathogenicity is determined by specific genetic markers and biological testing.

Wild aquatic birds, particularly those belonging to the orders Anseriformes, which includes ducks and geese, and Charadriiformes, which includes shorebirds and gulls, serve as the natural reservoir for avian influenza viruses and maintain the diverse pool of viral subtypes and strains circulating in nature. These birds typically carry low pathogenic strains that replicate in the intestinal tract and are shed in feces without causing clinical disease, allowing efficient viral transmission through contaminated water and environments. Migration patterns of wild birds facilitate the global spread of avian influenza viruses, introducing new strains to different geographic regions and creating opportunities for infection of domestic poultry that share habitats or water sources with wild populations.

Transmission of avian influenza to domestic poultry occurs through multiple pathways, with direct and indirect contact with infected wild birds representing the primary route of viral introduction. Contaminated water sources, particularly ponds and waterways used by both wild and domestic birds, serve as efficient transmission vehicles because the virus can survive for extended periods in water, especially at cool temperatures. Mechanical transmission via contaminated equipment, vehicles, footwear, clothing, and personnel who have had contact with infected birds or environments can introduce the virus to previously unaffected flocks. The trade and movement of live poultry, particularly through markets where birds from multiple sources are comingled, facilitates rapid viral spread within commercial and backyard poultry populations.

Environmental and management factors significantly influence the risk of avian influenza introduction and the severity of outbreaks once infection occurs. Operations with poor biosecurity, including inadequate perimeter fencing, shared equipment, limited personnel hygiene protocols, and unrestricted access by wild birds, face substantially higher risk of viral introduction. Geographic proximity to wetlands, flyways, and other areas with high wild bird activity increases exposure risk. Multi-age production systems, high stocking densities, and frequent movement of birds between locations all contribute to rapid viral dissemination once infection is established. Seasonality affects outbreak risk, with many regions experiencing increased activity during wild bird migration periods in spring and fall.

The pathogenesis of avian influenza differs markedly between low and highly pathogenic strains. Low pathogenic avian influenza viruses typically remain localized to the respiratory and intestinal tracts, causing limited tissue damage and mild clinical disease. In contrast, highly pathogenic avian influenza viruses contain genetic modifications, particularly in the hemagglutinin cleavage site, that enable systemic replication in multiple organs including the vascular endothelium, leading to widespread tissue damage, hemorrhage, and rapid death. The highly pathogenic phenotype can emerge through mutation of circulating low pathogenic H5 or H7 strains, typically following extended circulation in domestic poultry populations, underscoring the importance of controlling low pathogenic infections to prevent emergence of highly pathogenic variants.

The clinical presentation of avian influenza varies dramatically depending on the pathogenicity of the infecting strain, the species affected, and various host and environmental factors. Low pathogenic avian influenza typically causes mild respiratory disease that may go unnoticed in individual birds but becomes apparent at the flock level through decreased feed consumption, reduced egg production, and slightly increased mortality. Highly pathogenic avian influenza, in contrast, produces severe systemic disease with catastrophic mortality that can approach one hundred percent within days of infection in susceptible species such as chickens and turkeys. Recognizing the full spectrum of clinical signs associated with avian influenza is essential for early detection and rapid response to limit the spread and impact of outbreaks.

Early warning signs of avian influenza in commercial poultry flocks often include subtle changes in production parameters before individual birds show obvious clinical signs. Decreased feed and water consumption may be the first indication of developing infection, followed by reduced egg production in laying flocks and decreased growth rates in meat birds. A slight increase in mortality above expected baseline levels should prompt investigation, as early intervention is critical for containing outbreaks. Behavioral changes such as decreased activity, huddling, and reduced responsiveness to stimuli indicate developing illness and warrant immediate veterinary attention.

Respiratory signs are prominent features of both low and highly pathogenic avian influenza infections and may include nasal discharge, sneezing, coughing, and rattling or gurgling sounds during respiration. Swelling of the sinuses and tissues around the eyes creates a characteristic facial edema that may be more pronounced in turkeys than in chickens. Conjunctivitis with watery to purulent discharge commonly accompanies respiratory involvement. In severe cases, birds may show marked respiratory distress with open-mouth breathing, extended neck posture, and cyanosis of the comb and wattles due to inadequate oxygenation.

Systemic signs of highly pathogenic avian influenza reflect the widespread organ damage caused by viral replication throughout the body. Profound depression and lethargy progress rapidly to prostration as birds become increasingly ill. Cyanosis and hemorrhage of the comb, wattles, and legs produce the dramatic discoloration that historically gave the disease its name, fowl plague. Edema of the head and neck may be severe, and subcutaneous hemorrhages may be visible through the skin. Diarrhea, which may be watery or contain blood, reflects intestinal involvement. Neurological signs including tremors, abnormal head and neck postures, incoordination, and paralysis occur in some cases, particularly with certain viral strains.

Reproductive effects of avian influenza significantly impact laying flocks, with egg production dropping precipitously during acute infection. Production declines of fifty percent or more within days are commonly reported during highly pathogenic outbreaks, while low pathogenic infections may cause more modest reductions. Egg quality deteriorates with thin shells, abnormal shape, and loss of pigmentation. Reduced fertility and hatchability in breeder flocks result from both the direct effects of infection on the reproductive tract and the systemic illness affecting overall bird health. These production effects may persist for extended periods even in birds that recover from infection.

The speed of mortality is one of the most striking features differentiating highly pathogenic from low pathogenic avian influenza. In chickens infected with highly pathogenic strains, death may occur within hours of the onset of clinical signs, sometimes before any symptoms are observed, resulting in the sudden discovery of large numbers of dead birds without preceding illness. Mortality can exceed fifty percent within the first day of apparent disease and approach one hundred percent within two to three days. This extremely rapid disease progression severely limits opportunities for intervention and underscores the critical importance of prevention and early detection. Any sudden increase in mortality, particularly if accompanied by respiratory signs or production drops, should be considered a potential avian influenza emergency requiring immediate veterinary investigation and regulatory notification.

Diagnosis of avian influenza requires laboratory confirmation due to the similarity of clinical signs to other respiratory and systemic diseases of poultry and the regulatory implications of a positive diagnosis. While clinical presentation and epidemiological patterns may strongly suggest avian influenza, definitive identification of the virus and determination of its pathogenicity are essential for implementing appropriate response measures and meeting regulatory requirements. Rapid and accurate diagnosis is critical because delays in identifying highly pathogenic avian influenza can result in extensive viral spread and dramatically increased economic and public health consequences.

Clinical examination of affected birds and flocks provides initial information that helps prioritize differential diagnoses and guides sample collection. The distribution and severity of clinical signs within the flock, the speed of disease progression, and the mortality pattern all contribute valuable diagnostic information. Post-mortem examination of freshly dead birds reveals characteristic lesions including hemorrhages in multiple organs, congestion and edema of various tissues, and necrosis in the spleen, liver, and other visceral organs. However, lesions may be minimal or absent in peracute cases where birds die before significant tissue damage develops, and the variability of pathological findings necessitates laboratory testing for definitive diagnosis.

Laboratory diagnosis of avian influenza employs multiple complementary techniques to detect the virus, characterize its subtype, and determine its pathogenicity. Virus isolation in embryonated chicken eggs or cell culture remains the reference standard for detection and provides live virus for further characterization. Molecular techniques, particularly real-time reverse transcription polymerase chain reaction, offer rapid detection and subtyping with high sensitivity and specificity, enabling same-day results that are critical for outbreak response. Serological tests including hemagglutination inhibition and enzyme-linked immunosorbent assays detect antibodies against avian influenza viruses and are valuable for surveillance and flock monitoring, although they cannot distinguish between antibodies from vaccination and those from natural infection without additional testing.

Differential diagnosis for avian influenza includes numerous other respiratory, systemic, and neurological diseases that may produce similar clinical presentations. Newcastle disease, another reportable viral disease causing respiratory and neurological signs with high mortality, must be distinguished from highly pathogenic avian influenza through specific testing. Infectious bronchitis, infectious laryngotracheitis, and other respiratory pathogens cause similar respiratory signs but typically lack the systemic manifestations and extreme mortality of highly pathogenic avian influenza. Fowl cholera and other bacterial septicemias may produce acute mortality and hemorrhagic lesions resembling avian influenza. Mycotoxicosis and various poisonings should be considered when flocks experience sudden mortality. Given the regulatory significance of avian influenza diagnosis, samples should be submitted to official or accredited laboratories capable of performing the full range of required testing, and positive results may require confirmation by national reference laboratories.

There is no approved treatment for avian influenza in poultry, and regulatory frameworks in most countries mandate depopulation of infected flocks rather than treatment in order to control the disease and prevent further spread. This stamping-out policy reflects the highly contagious nature of the virus, the speed with which it can spread through susceptible populations, and the potential public health implications of allowing ongoing viral circulation. While the economic consequences of depopulation are severe for affected producers, this approach remains the international standard for responding to highly pathogenic avian influenza outbreaks and is considered essential for protecting the broader poultry industry and public health.

For low pathogenic avian influenza infections, regulatory responses may vary depending on the viral subtype, geographic location, and prevailing policies. Some jurisdictions may permit controlled marketing of infected flocks under specific conditions, while others require depopulation similar to highly pathogenic strains, particularly for H5 and H7 subtypes that have the potential to mutate to highly pathogenic forms. In either case, movement restrictions, enhanced surveillance, and intensive monitoring of affected and at-risk flocks are implemented to prevent spread. The decision-making process involves regulatory authorities, veterinary officials, and producers working together to implement responses that balance disease control objectives with practical and economic considerations.

Supportive care for infected birds is generally not pursued because treatment does not eliminate viral shedding, does not prevent transmission to other birds, and would prolong the outbreak duration while increasing the risk of further spread. Antiviral medications approved for human use have been investigated in poultry but are not approved for this purpose, would be prohibitively expensive for commercial application, and their use could potentially promote development of drug-resistant strains that would compromise human treatment options. Additionally, administering medications to food-producing animals that will be marketed for consumption would raise food safety and withdrawal time concerns that further complicate any treatment approach.

Depopulation of infected and exposed flocks must be conducted rapidly and humanely to minimize suffering and prevent ongoing viral shedding. Methods approved for mass depopulation include ventilation shutdown with supplemental heat, carbon dioxide gassing, water-based foam suffocation, and other approaches approved by regulatory authorities and animal welfare guidelines. The selection of method depends on the species and number of birds affected, available equipment and resources, and specific circumstances of the outbreak. Following depopulation, thorough cleaning and disinfection of premises is required before restocking, with the duration of the fallowing period determined by regulatory requirements and confirmation of successful decontamination.

Compensation programs in many countries provide financial assistance to producers whose flocks are depopulated due to avian influenza, recognizing that producers bear individual losses for actions taken to protect the broader public good. However, compensation may not fully cover all losses, including future production, contract penalties, and business disruption costs. Insurance products may provide additional coverage, although availability and terms vary. Producers should familiarize themselves with applicable compensation programs and insurance options before outbreaks occur, as part of comprehensive emergency preparedness planning. Working with industry associations and regulatory agencies helps ensure that producers understand their options and can access available support during the stressful period following an outbreak.

While treatment of infected birds is not pursued, supportive measures for uninfected birds in affected areas focus on maintaining their health and preventing viral spread while movement restrictions are in effect. Enhanced biosecurity, reduced stress through optimal management, and vigilant monitoring for any signs of disease help protect susceptible flocks during outbreak responses. Vaccination may be permitted or required in some jurisdictions as part of outbreak response or prevention strategies, although its use is subject to regulatory approval and may have trade implications. Consultation with regulatory veterinary authorities is essential for understanding applicable requirements and available options during any avian influenza incident.

Recovery in the traditional sense does not apply to avian influenza management in most commercial poultry contexts because regulatory frameworks mandate depopulation of infected flocks rather than allowing birds to recover from infection. The concept of recovery is therefore more applicable at the farm, regional, and industry levels as operations resume following successful disease control and eradication efforts. This recovery process involves extensive cleaning and disinfection, regulatory verification of pathogen elimination, and eventual restocking with birds from uninfected sources, typically under enhanced biosecurity and monitoring protocols.

The timeline for returning to production following an avian influenza outbreak depends on multiple factors including the scope of the outbreak, the success of cleaning and disinfection efforts, regulatory requirements for premises release, and the availability of replacement stock. Following depopulation, thorough cleaning to remove all organic material is required before disinfection can be effective. Disinfection protocols using approved products must achieve documented reduction of viral contamination. A fallowing period, typically ranging from several weeks to months depending on jurisdiction and circumstances, allows any residual virus to become non-infectious before new birds are introduced. Environmental testing may be required to verify successful decontamination before premises are released for restocking.

Prognosis for individual birds that survive low pathogenic avian influenza infection is generally favorable, with most recovering full health and production capability within several weeks. However, the regulatory and practical constraints on maintaining recovered birds in commercial settings often make this academic. In backyard or hobby flocks where depopulation may not be mandated for low pathogenic infections, recovered birds may return to production but should be monitored for any recurrence of signs and may pose ongoing biosecurity concerns. Survivors develop immunity to the infecting strain but remain susceptible to other influenza subtypes and variants, and their potential for persistent viral shedding must be considered in management decisions.

Return to production considerations at the flock and farm level extend beyond simply restocking to include evaluation and enhancement of biosecurity measures that failed to prevent the original introduction. Root cause analysis identifying how the virus entered the premises informs improvements to prevent recurrence. Upgraded biosecurity infrastructure, revised protocols for personnel and vehicle movement, enhanced wild bird exclusion measures, and improved surveillance programs should be implemented before restocking. Staff retraining ensures that all personnel understand the importance of biosecurity and their role in protecting the new flock from future disease introductions.

Vaccination against avian influenza is available and used in some countries as part of comprehensive control programs, although its application is subject to regulatory restrictions and may have implications for international trade. Inactivated oil-emulsion vaccines and recombinant vector vaccines provide protection against clinical disease and reduce viral shedding, thereby decreasing environmental contamination and transmission potential. However, vaccination does not provide complete protection, and vaccinated birds may become infected and shed virus without showing clinical signs, potentially serving as silent sources of infection. For these reasons, vaccination is typically used in conjunction with rather than as a replacement for robust biosecurity and surveillance programs.

Biosecurity represents the primary defense against avian influenza introduction and is essential regardless of whether vaccination is employed. Structural biosecurity includes perimeter fencing to exclude wild birds and unauthorized visitors, bird-proof housing that prevents contact between domestic poultry and wild species, and controlled access points with appropriate cleaning and disinfection facilities. Operational biosecurity encompasses protocols for personnel hygiene including footwear changes and hand washing, vehicle and equipment cleaning procedures, control of visitor access, and management practices that minimize contamination risk. Conceptual biosecurity involves risk awareness, training, and the commitment of all personnel to maintaining protective measures consistently.

Specific measures to reduce wild bird contact are particularly important for avian influenza prevention given the role of wild waterfowl as natural reservoirs. Eliminating standing water sources that attract wild birds, including puddles, ponds, and poorly drained areas near poultry houses, reduces opportunities for environmental contamination. Covering or screening outdoor areas used by poultry prevents direct contact with wild bird droppings. Feed storage must be secure against wild bird access, and spilled feed should be promptly cleaned to avoid attracting wildlife. Monitoring for wild bird presence and activity near poultry facilities enables timely enhancement of protective measures when risk is elevated.

Surveillance and monitoring programs provide early warning of viral circulation, enabling rapid response before extensive spread occurs. Active surveillance involves regular testing of poultry populations for evidence of infection, with sampling strategies designed to detect virus at low prevalence levels. Passive surveillance relies on investigation of clinical disease and mortality events that might indicate avian influenza. Wild bird surveillance monitors circulating strains in reservoir populations, providing information about viruses that might be introduced to domestic poultry. Integration of surveillance data across domestic poultry, wild birds, and other species creates a comprehensive picture of avian influenza activity and risk.

Quarantine and testing protocols for bird introductions provide crucial protection against importing infection through movement of live poultry. All new birds should be sourced from flocks with known health status and documentation of freedom from avian influenza. Quarantine of incoming birds for a minimum of two to three weeks, with testing before release into the main flock, allows detection of infections that might not have been apparent at the time of purchase. Complete biosecurity separation between quarantine and production areas prevents any potential transmission during the observation period. Similar precautions apply to birds returning from shows, exhibitions, or other off-farm activities where exposure to unknown birds may have occurred.

Daily management and monitoring practices form the foundation of avian influenza preparedness and enable early detection that is critical for effective outbreak response. Routine observation of bird behavior, feed and water consumption, production parameters, and mortality levels establishes baseline expectations against which abnormalities can be detected. Any deviation from normal patterns should prompt investigation and potentially veterinary consultation. Record keeping that documents daily observations creates a historical record that helps identify trends and supports regulatory reporting requirements. Training all personnel who have contact with birds to recognize signs of illness and report concerns promptly ensures that potential problems receive timely attention.

Housing and environmental management significantly influence disease risk and should be designed and maintained with avian influenza prevention as a priority. Housing should be constructed to prevent wild bird entry through properly screened ventilation openings, maintained doors and walls without gaps, and bird-proof roofing. Ventilation systems should provide adequate air quality while minimizing the potential for airborne virus introduction. Flooring and surfaces should be constructed of materials that can be effectively cleaned and disinfected. Surrounding areas should be maintained to discourage wild bird congregation, with short vegetation, absence of standing water, and removal of features that attract wildlife.

Comprehensive flock health programs integrate biosecurity, surveillance, and management practices into systematic approaches that protect flocks from avian influenza and other diseases. Written protocols documenting all biosecurity procedures ensure consistency and provide training resources for personnel. Regular review and updating of protocols incorporates lessons learned and addresses emerging risks. Integration with veterinary services ensures access to professional guidance for disease prevention and response. Participation in industry health programs and regulatory surveillance schemes demonstrates commitment to disease control and may provide early warning of regional disease activity.

Record keeping and monitoring systems specific to avian influenza preparedness include documentation of biosecurity compliance, visitor logs, vehicle movement records, and any contacts with wild birds or unusual mortality events. These records support epidemiological investigation if outbreaks occur and demonstrate due diligence in disease prevention efforts. Production records that track feed consumption, weight gain or egg production, and mortality enable early detection of abnormalities that might indicate developing infection. Maintenance of current contact information for regulatory authorities and veterinary services ensures rapid communication capabilities during emergency situations.

Economic considerations for avian influenza preparedness include the costs of biosecurity infrastructure and operational measures, surveillance testing, vaccination where applicable, and business interruption insurance. While these investments represent significant expenses, they must be weighed against the potentially catastrophic losses from an outbreak, including complete flock depopulation, extended downtime, and reputational damage. Cost-benefit analysis typically demonstrates that prevention investments provide substantial returns compared to outbreak costs. Government cost-sharing programs may be available to support biosecurity improvements or surveillance activities. Industry associations can provide guidance on cost-effective approaches to meeting biosecurity standards and may facilitate access to shared resources or expertise.

All breeds of domestic chickens are susceptible to avian influenza, with no documented genetic resistance to infection among commercial or heritage poultry populations. However, the consequences of infection may vary depending on the production type and management system. Commercial layer and broiler strains raised in high-density confinement systems may experience more rapid viral spread once infection is introduced due to the close proximity of large numbers of susceptible birds. Free-range and pasture-based operations face elevated risk of initial viral introduction through contact with wild birds but may experience slower within-flock transmission due to lower bird densities. Heritage and rare breeds are equally susceptible to infection and may face conservation concerns if populations are significantly affected by depopulation orders.

Species susceptibility to avian influenza varies considerably, with chickens and turkeys being highly susceptible to both clinical disease and mortality from highly pathogenic strains. Domestic ducks and geese are generally more resistant to clinical disease and may carry and shed virus with minimal or no clinical signs, creating potential for silent transmission to more susceptible species. This differential susceptibility has important implications for mixed-species operations or situations where waterfowl may share environments with chickens or turkeys. Game birds including pheasants, partridges, and quail are susceptible to avian influenza and may serve as bridge species between wild reservoirs and commercial poultry in areas where game bird rearing occurs near wild bird habitats.

Genetic selection for avian influenza resistance has received research attention, and some studies have identified genetic markers associated with differential susceptibility or response to infection. However, practical application of genetic selection for disease resistance remains limited due to the complex nature of host-pathogen interactions and the priority given to production traits in commercial breeding programs. Maintaining genetic diversity within poultry populations may provide some population-level resilience by ensuring that susceptibility is not uniform across all individuals. Breeding stock suppliers typically implement intensive biosecurity and surveillance programs to protect the genetic resources upon which the commercial poultry industry depends.

Several conditions commonly co-occur with or complicate avian influenza infections, and understanding these associations aids in diagnosis and management. Immunosuppressive diseases including infectious bursal disease, chicken anemia virus, and Marek's disease compromise host immune responses and may increase susceptibility to avian influenza or exacerbate clinical disease severity. Concurrent respiratory infections with bacteria such as Escherichia coli, Pasteurella multocida, or mycoplasma species can complicate the clinical picture and worsen outcomes. Nutritional deficiencies or other stress factors that compromise immune function may similarly increase vulnerability to infection and disease severity.

Conditions with similar clinical presentations must be differentiated from avian influenza due to the dramatically different response measures they require. Newcastle disease, caused by virulent strains of avian paramyxovirus type 1, produces respiratory and neurological signs with potentially high mortality that closely resembles highly pathogenic avian influenza, and both are reportable diseases requiring immediate regulatory notification. Infectious laryngotracheitis causes severe respiratory distress with bloody exudate that might be confused with avian influenza respiratory involvement. Fowl cholera and other bacterial septicemias can produce acute mortality with hemorrhagic lesions. Accurate laboratory diagnosis is essential for distinguishing between these conditions and implementing appropriate response measures.

Complications and sequelae of avian influenza infection include secondary bacterial infections that may develop in damaged respiratory tissues, reduced production that may persist for extended periods in flocks that survive low pathogenic infections, and the emergence of highly pathogenic strains from circulating low pathogenic H5 and H7 viruses through mutation during extended circulation in domestic poultry. The zoonotic potential of certain avian influenza strains represents a complication with public health significance, requiring attention to worker safety during outbreak response activities. Economic sequelae including trade restrictions, market disruptions, and loss of consumer confidence may affect the broader poultry industry well beyond the directly affected farms and persist long after the disease itself is controlled.